Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Relevance of Drug-drug Interactions (DDI) With the Currently Used Direct-acting Antiviral Therapy (DAA) Against Hepatitis C Virus (HCV)

NCT06928259 is registered in ClinicalTrials.gov with University of Seville as lead sponsor.

NCT NCT06928259
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06928259 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Relevance of Drug-drug Interactions (DDI) With the Currently Used Direct-acting Antiviral Therapy (DAA) Against Hepatitis C Virus (HCV)
Lead sponsor
University of Seville
Phase
Observational
Overall status
Recruiting
Start date
April 30, 2025
Completion date
March 31, 2026
Enrollment
728 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

hcv infection